SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HCA Healthcare Corporation (NYSE: HCA)(was COL)
HCA 472.10-1.4%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thomas J Pittman who wrote ()10/25/1999 11:57:00 AM
From: leigh aulper   of 345
 
Columbia/HCA Earnings Beat Forecasts

.c The Associated Press

NASHVILLE, Tenn. (AP) - Columbia/HCA Healthcare Corp.'s third quarter earnings rose 18 percent, excluding restructuring costs and legal fees related to a federal fraud investigation, as the nation's largest hospital chain benefitted from higher patient admissions.

Earnings from continuing operations were $155 million, or 27 cents per share, compared to $131 million or 20 cents per share a year ago. Results beat Wall Street forecasts by two cents, according to First Call/Thomson Financial.

Including the one-time costs, net income in the quarter was $138 million, or 24 cents per share, compared to $146 million, or 22 cents per share.

Revenues fell 15 percent to $3.9 billion from $4.6 billion. The decline reflects the sale or spin-off of about 100 hospitals and more than 20 ambulatory surgery centers since September 1998. Nashville-based Columbia now operates 214 hospitals and 84 ambulatory surgery centers.

The restructuring was prompted by a federal investigation into allegations the company systematically overcharged government health programs. Columbia officials are negotiating with the federal government in an attempt to end the 2 1/2-year-old investigation.

Two Columbia middle managers in Florida were convicted last summer of conspiring to defraud and defrauding several government health insurance programs.

Same facility admissions increased a healthy 2 percent in the quarter - the fourth straight quarter of such increases - and same facility revenue was up 5.8 percent.

Columbia officials said earnings were depressed by lower Medicaid fees, increased drug costs and higher bad debts.

Columbia shares were unchanged at $21.75 in early trading on the New York Stock Exchange.

For the first nine months of the year, Columbia earned $566 million, or 95 cents per share, compared to $421 million, or 65 cents per share a year ago. Revenues fell 11 percent to $12.7 billion from $14.3 billion.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext